An in silico Approach for Integrating Phenotypic and Target‐based Approaches in Drug Discovery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An in silico Approach for Integrating Phenotypic and Target‐based Approaches in Drug Discovery

Published:2019-10-22 Issue:1-2 Volume:39 Page:1900096
ISSN:1868-1743
Container-title:Molecular Informatics
language:en
Short-container-title:Mol. Inf.

Author:

Iwata Hiroaki¹²,Kojima Ryosuke¹,Okuno Yasushi¹²³

Affiliation:

1. Graduate School of MedicineKyoto University 53 Shogoin-kawaharacho Sakyo-ku Kyoto 606-8507 Japan

2. Medical Sciences Innovation Hub Program, RIKEN Cluster for ScienceTechnology and Innovation Hub, Tsurumi-ku Kanagawa 230-0045 Japan

3. Foundation for Biomedical Research and Innovation at KobeCenter for Cluster Development and Coordination, Chuo-ku, Kobe Hyogo 650-0047 Japan

Funder

New Energy and Industrial Technology Development Organization

Publisher

Wiley

Subject

Organic Chemistry,Computer Science Applications,Drug Discovery,Molecular Medicine,Structural Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/minf.201900096

Reference40 articles.

1.

2. The utility of target-based discovery

3. Phenotypic screens as a renewed approach for drug discovery

4. Phenotypic vs. Target-Based Drug Discovery for First-in-Class Medicines

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico drug discovery: a machine learning-driven systematic review;Medicinal Chemistry Research;2024-06-15

2. Predicting molecular docking of per- and polyfluoroalkyl substances to blood protein using generative artificial intelligence algorithm DiffDock;BioTechniques;2024-01

3. Application of <i>in Silico</i> Technologies for Drug Target Discovery and Pharmacokinetic Analysis;Chemical and Pharmaceutical Bulletin;2023-06-01

4. Advances of the Target-Based and Phenotypic Screenings and Strategies in Drug Discovery;International Journal of Drug Discovery and Pharmacology;2022-12-21

5. How artificial intelligence enables modeling and simulation of biological networks to accelerate drug discovery;Frontiers in Drug Discovery;2022-10-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3